Article from https://www.independent.co.uk/news/eu-regulator-starts-safety-review-coronavirus-drug-eu-european-medicines-agency-regulator-patients-remdesivir-b749229.html also the guardian is reporting this.
Reminder that early tests of MPL show it to be notably similar to the inhibition demonstrated for remdesivir but with a strong safety profile behind it.
^ From company ann 9th September.
PAA is currently evaluating the use of MPL for COVID in EUROPE. I hope the board is at least reaching out to the EMA with some early data and getting MPL on their radar.
- Forums
- ASX - By Stock
- PAA
- EMA starts safety review of Remdesivir after causing acute kidney pain in several patients
EMA starts safety review of Remdesivir after causing acute kidney pain in several patients
-
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PAA (ASX) to my watchlist
|
|||||
Last
21.0¢ |
Change
0.015(7.69%) |
Mkt cap ! $93.45M |
Open | High | Low | Value | Volume |
20.0¢ | 21.5¢ | 19.5¢ | $459.0K | 2.222M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 103700 | 20.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
21.5¢ | 127225 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 104457 | 0.215 |
1 | 50000 | 0.210 |
2 | 103700 | 0.205 |
9 | 363026 | 0.200 |
8 | 256849 | 0.195 |
Price($) | Vol. | No. |
---|---|---|
0.200 | 10000 | 1 |
0.215 | 132225 | 4 |
0.220 | 124118 | 2 |
0.230 | 76179 | 2 |
0.240 | 25634 | 1 |
Last trade - 16.10pm 11/07/2024 (20 minute delay) ? |
Featured News
PAA (ASX) Chart |